Creation of a drug fund for post-clinical trial access to antiretrovirals
- 1 July 2004
- journal article
- Published by Elsevier in The Lancet
- Vol. 364 (9428) , 101-102
- https://doi.org/10.1016/s0140-6736(04)16596-3
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- WMA postpones decision to amend Declaration of HelsinkiThe Lancet, 2003
- Not if but how? Caring for HIV-1 vaccine trial participants in South AfricaThe Lancet, 2003
- Provision of treatment in HIV-1 vaccine trials in developing countriesThe Lancet, 2003
- Thorny issues in the ethics of AIDS vaccine trialsThe Lancet, 2003
- Establishing ethical trials for treatment and prevention of AIDS in developing countriesBMJ, 2003
- Developing a Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Therapeutic Research Agenda for Resource‐Limited Countries: A Consensus StatementClinical Infectious Diseases, 2003
- Enhanced: The Need for a Global HIV Vaccine EnterpriseScience, 2003
- Investigators' Responsibilities for Human Subjects in Developing CountriesNew England Journal of Medicine, 2000